The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations
- PMID: 26030634
- DOI: 10.7326/M14-2385
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations
Abstract
The PRISMA statement is a reporting guideline designed to improve the completeness of reporting of systematic reviews and meta-analyses. Authors have used this guideline worldwide to prepare their reviews for publication. In the past, these reports typically compared 2 treatment alternatives. With the evolution of systematic reviews that compare multiple treatments, some of them only indirectly, authors face novel challenges for conducting and reporting their reviews. This extension of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) statement was developed specifically to improve the reporting of systematic reviews incorporating network meta-analyses. A group of experts participated in a systematic review, Delphi survey, and face-to-face discussion and consensus meeting to establish new checklist items for this extension statement. Current PRISMA items were also clarified. A modified, 32-item PRISMA extension checklist was developed to address what the group considered to be immediately relevant to the reporting of network meta-analyses. This document presents the extension and provides examples of good reporting, as well as elaborations regarding the rationale for new checklist items and the modification of previously existing items from the PRISMA statement. It also highlights educational information related to key considerations in the practice of network meta-analysis. The target audience includes authors and readers of network meta-analyses, as well as journal editors and peer reviewers.
Comment in
-
The PRISMA extension for network meta-analysis: bringing clarity and guidance to the reporting of systematic reviews incorporating network meta-analyses.Ann Intern Med. 2015 Jun 2;162(11):797-8. doi: 10.7326/M15-0930. Ann Intern Med. 2015. PMID: 26030637 No abstract available.
-
The PRISMA Extension Statement.Ann Intern Med. 2015 Oct 6;163(7):566. doi: 10.7326/L15-5144. Ann Intern Med. 2015. PMID: 26436628 No abstract available.
-
The PRISMA Extension Statement.Ann Intern Med. 2015 Oct 6;163(7):566-7. doi: 10.7326/L15-5144-2. Ann Intern Med. 2015. PMID: 26436629 No abstract available.
Similar articles
-
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.J Clin Epidemiol. 2009 Oct;62(10):e1-34. doi: 10.1016/j.jclinepi.2009.06.006. Epub 2009 Jul 23. J Clin Epidemiol. 2009. PMID: 19631507
-
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.Ann Intern Med. 2009 Aug 18;151(4):W65-94. doi: 10.7326/0003-4819-151-4-200908180-00136. Epub 2009 Jul 20. Ann Intern Med. 2009. PMID: 19622512
-
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.BMJ. 2009 Jul 21;339:b2700. doi: 10.1136/bmj.b2700. BMJ. 2009. PMID: 19622552 Free PMC article.
-
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.PLoS Med. 2009 Jul 21;6(7):e1000100. doi: 10.1371/journal.pmed.1000100. Epub 2009 Jul 21. PLoS Med. 2009. PMID: 19621070 Free PMC article.
-
Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.J Clin Epidemiol. 2016 Feb;70:68-89. doi: 10.1016/j.jclinepi.2015.09.001. Epub 2015 Sep 5. J Clin Epidemiol. 2016. PMID: 26348799
Cited by
-
Delivery Room Interventions for Hypothermia in Preterm Neonates: A Systematic Review and Network Meta-analysis.JAMA Pediatr. 2021 Sep 1;175(9):e210775. doi: 10.1001/jamapediatrics.2021.0775. Epub 2021 Sep 7. JAMA Pediatr. 2021. PMID: 34028513 Free PMC article.
-
Chinese herbal injections versus intrapleural cisplatin for lung cancer patients with malignant pleural effusion: A Bayesian network meta-analysis of randomized controlled trials.Front Oncol. 2022 Sep 20;12:942941. doi: 10.3389/fonc.2022.942941. eCollection 2022. Front Oncol. 2022. PMID: 36203451 Free PMC article.
-
Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis.Front Endocrinol (Lausanne). 2020 Aug 19;11:553. doi: 10.3389/fendo.2020.00553. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32973680 Free PMC article.
-
Efficacy of preventive use of oxygen therapy after planned extubation in high-risk patients with extubation failure: A network meta-analysis of randomized controlled trials.Front Med (Lausanne). 2022 Oct 13;9:1026234. doi: 10.3389/fmed.2022.1026234. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36314016 Free PMC article.
-
Assessing the Potential Association Between Microbes and Corrosion of Intra-Oral Metallic Alloy-Based Dental Appliances Through a Systematic Review of the Literature.Front Bioeng Biotechnol. 2021 Mar 15;9:631103. doi: 10.3389/fbioe.2021.631103. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 33791285 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous